Ixchelsis Limited
- Total Funding
- $26.0M
- Last Round
- $12.0M Venture RoundDec 2016
- Rounds
- 2
About
Oxytocin receptor antagonists for benign prostatic hypertrophy
Summary
Ixchelsis Limited is a Biotech company. It has raised $26.0M in total across 2 rounds, most recently a $12.0M Venture Round round in Dec 2016. Investors include Pfizer Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2016
Sign up to see all 2 rounds
Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ixchelsis-limited"><img src="https://indexed.vc/api/badge/company/ixchelsis-limited" alt="Ixchelsis Limited on Indexed.vc" width="260" height="76" /></a>